These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1568172)

  • 1. Cervical and vaginal cancer associated with pessary use.
    Schraub S; Sun XS; Maingon P; Horiot JC; Daly N; Keiling R; Pigneux J; Pourquier H; Rozan R; Vrousos C
    Cancer; 1992 May; 69(10):2505-9. PubMed ID: 1568172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cervico-vaginal carcinoma and pessary. A further characteristic case].
    Amalric R; Heftman M; Ayme Y; Spitalier JM
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(3):308-9. PubMed ID: 5479054
    [No Abstract]   [Full Text] [Related]  

  • 3. How innocent is the vaginal pessary? Two cases of vaginal cancer associated with pessary use.
    Jain A; Majoko F; Freites O
    J Obstet Gynaecol; 2006 Nov; 26(8):829-30. PubMed ID: 17130056
    [No Abstract]   [Full Text] [Related]  

  • 4. What is hiding behind the pessary?
    Martin C; Hong L; Siddighi S
    Int Urogynecol J; 2013 May; 24(5):873-5. PubMed ID: 22790489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervico-vaginal carcinoma and pessaries].
    Vigne J; Ayme Y; Dies M; Erny R; Spitalier JM
    Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(5):542-5. PubMed ID: 5386407
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary adenocarcinoma of the vagina due to the use of a pessary].
    Lamotte G
    Bull Soc R Belge Gynecol Obstet; 1969; 39(4):287-94. PubMed ID: 5399902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical analysis of 13 cases with vaginal intraepithelial neoplasia].
    Yang Y; Gao YL; Yu AJ; Zhang JJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):197-200. PubMed ID: 20450756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
    Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
    Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
    Dueñas JL; Miceli A
    Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
    Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated pelvic recurrences of cervical carcinoma treated with salvage chemoradiotherapy].
    Besson N; Touboul E; Daraï É; Lefranc JP; Monnier L; Schlienger M; Huguet F
    Cancer Radiother; 2014 Mar; 18(2):83-8. PubMed ID: 24462252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine cervical and vaginal verrucous squamous cell carcinoma.
    Faaborg LL; Smith ML; Newland JR
    Gynecol Oncol; 1979 Aug; 8(1):104-9. PubMed ID: 456932
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pessary placement and management.
    Palumbo MV
    Ostomy Wound Manage; 2000 Dec; 46(12):40-5. PubMed ID: 11890135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of cancer of the vagina.
    Tindall VR
    Clin Obstet Gynaecol; 1976 Aug; 3(2):243-56. PubMed ID: 1009722
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal Pessary Care: A Modified Delphi Consensus Study.
    Hooper GL; Atnip S; O'Dell K
    J Midwifery Womens Health; 2017 Jul; 62(4):452-462. PubMed ID: 28727233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma.
    Miyazaki K; Yamaguchi K; Tohya T; Ohba T; Takatsuki K; Okamura H
    Obstet Gynecol; 1991 Jan; 77(1):107-10. PubMed ID: 1984208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of an adolescent with locally advanced cervicovaginal clear cell adenocarcinoma using definitive chemotherapy and radiotherapy.
    Ansari DO; Horowitz IR; Katzenstein HM; Durham MM; Esiashvili N
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):e174-6. PubMed ID: 22713709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse.
    Clemons JL; Aguilar VC; Tillinghast TA; Jackson ND; Myers DL
    Am J Obstet Gynecol; 2004 Feb; 190(2):345-50. PubMed ID: 14981372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal cancer possibly caused by pessary and immunocompromised condition: Multiple risk factors may influence vaginal cancer development.
    Akino N; Wada-Hiraike O; Matsumoto Y; Arimoto T; Oda K; Kawana K; Osuga Y; Fujii T
    J Obstet Gynaecol Res; 2016 Jun; 42(6):748-751. PubMed ID: 26914159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.